Drugs / Tetanus toxoid adsorbed booster vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00282308 | Jan 2006 → Jan 2008 | rheumatoid arthritis | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus toxoid adsorbed booster vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00282308 ↗ |
| Modality | Vaccine | “Tetanus toxoid, pneumococcal polysaccharide, and KLH vaccines” PMID 20039397 ↗ Jan 2010 |
| Route | Intramuscular | “patients received a tetanus toxoid adsorbed booster vaccine (1 mg in 0.5 mL) intramuscular (IM) injection” NCT00282308 ↗ |